Parietal epithelial cells maintain the epithelial cell continuum forming Bowman's space in focal segmental glomerulosclerosis.
Bowman's space
Epithelial continuum
Focal segmental glomerulosclerosis
Munich Wister Frömter rat
Parietal epithelial cells
Journal
Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
received:
25
06
2020
accepted:
24
11
2021
pubmed:
21
12
2021
medline:
3
5
2022
entrez:
20
12
2021
Statut:
ppublish
Résumé
In the glomerulus, Bowman's space is formed by a continuum of glomerular epithelial cells. In focal segmental glomerulosclerosis (FSGS), glomeruli show segmental scarring, a result of activated parietal epithelial cells (PECs) invading the glomerular tuft. The segmental scars interrupt the epithelial continuum. However, non-sclerotic segments seem to be preserved even in glomeruli with advanced lesions. We studied the histology of the segmental pattern in Munich Wistar Frömter rats, a model for secondary FSGS. Our results showed that matrix layers lined with PECs cover the sclerotic lesions. These PECs formed contacts with podocytes of the uninvolved tuft segments, restoring the epithelial continuum. Formed Bowman's spaces were still connected to the tubular system. In biopsies of patients with secondary FSGS, we also detected matrix layers formed by PECs, separating the uninvolved from the sclerotic glomerular segments. PECs have a major role in the formation of glomerulosclerosis; we show here that in FSGS they also restore the glomerular epithelial cell continuum that surrounds Bowman's space. This process may be beneficial and indispensable for glomerular filtration in the uninvolved segments of sclerotic glomeruli.
Identifiants
pubmed: 34927672
pii: 273803
doi: 10.1242/dmm.046342
pmc: PMC8938403
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2022. Published by The Company of Biologists Ltd.
Déclaration de conflit d'intérêts
Competing interests The authors declare no competing or financial interests.
Références
J Am Soc Nephrol. 2011 Jul;22(7):1262-74
pubmed: 21719782
Nat Rev Nephrol. 2015 Feb;11(2):76-87
pubmed: 25447132
J Am Soc Nephrol. 2009 Dec;20(12):2604-15
pubmed: 19917779
Clin J Am Soc Nephrol. 2012 Nov;7(11):1852-8
pubmed: 22917699
Am J Pathol. 2014 Dec;184(12):3239-48
pubmed: 25307344
Nephrol Dial Transplant. 2003 Aug;18 Suppl 6:vi39-44
pubmed: 12953041
Mod Pathol. 1988 Jul;1(4):292-315
pubmed: 3070555
Lab Invest. 2012 Apr;92(4):499-510
pubmed: 22249313
Methods Inf Med. 2007;46(3):292-9
pubmed: 17492115
Pflugers Arch. 2017 Aug;469(7-8):983-988
pubmed: 28664408
Kidney Int. 1992 Jul;42(1):148-60
pubmed: 1635344
Am J Kidney Dis. 2021 Dec;78(6):897-901
pubmed: 34118304
Kidney Int. 2005 Oct;68(4):1562-72
pubmed: 16164633
Cell Tissue Res. 2017 Jul;369(1):237-244
pubmed: 28361304
Nat Commun. 2019 Jul 24;10(1):3303
pubmed: 31341160
Front Med (Lausanne). 2018 Oct 30;5:292
pubmed: 30425988
Kidney Int. 2019 Jul;96(1):80-93
pubmed: 31029503
J Am Soc Nephrol. 2017 May;28(5):1408-1420
pubmed: 27895155
Nat Rev Nephrol. 2014 Mar;10(3):158-73
pubmed: 24468766
Am J Physiol Renal Physiol. 2020 Mar 1;318(3):F741-F753
pubmed: 32068458
Ren Physiol Biochem. 1991 Nov-Dec;14(6):246-52
pubmed: 1720255
Kidney Int. 2015 Nov;88(5):990-8
pubmed: 25853334
Sci Rep. 2017 Sep 13;7(1):11473
pubmed: 28904359
J Am Soc Nephrol. 1998 Mar;9(3):381-96
pubmed: 9513900
Curr Opin Nephrol Hypertens. 2007 May;16(3):184-91
pubmed: 17420660
J Hypertens. 2012 Oct;30(10):2031-8
pubmed: 22871889
Postdoc J. 2013 Apr;1(4):33-45
pubmed: 27583259
Kidney Int. 2018 Dec;94(6):1111-1126
pubmed: 30385042
Hum Pathol. 1982 Jul;13(7):651-60
pubmed: 7084942
Kidney Int. 2018 Mar;93(3):626-642
pubmed: 29276101